跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Residron
Approved
STANDARD
Residron
Pharmaten S.A.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
b34da2831928e0f7
Company
Pharmaten S.A.
Type
Standard
Approval Details
Approval Id
b34da2831928e0f7
Drug Approval Philippines Name
Residron
Product Name
Residron
Registration Number
DR-XY45055
Brand Name
Residron
Generic Name
Risedronate Sodium
Dosage Form
Tablet
Dosage Strength
35 mg
Manufacturer
Pharmaten S.A.
Importer
Metro Drug Inc.
Distributor
Metro Drug Inc.
Issuance Date
29 November 2021
Expiry Date
15 February 2026
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
b34da2831928e0f7
Type
Standard
Back to Philippines FDA Approvals
Residron - Philippines FDA Drug Approval Details